IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)

NCT03055806 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Premature Ejaculation

Interventions

DRUG: IX-01 400 mg
DRUG: Placebo
DRUG: IX-01 800 mg
DRUG: IX-01 1200 mg

Sponsor

Ixchelsis Limited